Published in J Neuropsychiatry Clin Neurosci on January 01, 1990
Neurosurgical and related interventions for the treatment of patients with psychiatric disorders. J Neuropsychiatry Clin Neurosci (1990) 0.75
Masked presentations of emotional facial expressions modulate amygdala activity without explicit knowledge. J Neurosci (1998) 7.85
Diagnostic criteria for schwannomatosis. Neurology (2005) 3.41
In vivo magnetic resonance imaging of transgene expression. Nat Med (2000) 3.35
The emotional counting Stroop paradigm: a functional magnetic resonance imaging probe of the anterior cingulate affective division. Biol Psychiatry (1998) 3.20
Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop. Biol Psychiatry (1999) 2.95
Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry (1994) 2.70
The counting Stroop: an interference task specialized for functional neuroimaging--validation study with functional MRI. Hum Brain Mapp (1998) 2.52
Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses. Nat Med (1999) 2.42
A symptom provocation study of posttraumatic stress disorder using positron emission tomography and script-driven imagery. Arch Gen Psychiatry (1996) 2.22
Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors. Hum Gene Ther (1998) 2.13
Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Am J Psychiatry (1999) 2.03
Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320. Nat Cell Biol (2011) 1.98
Simulated brain tumor growth dynamics using a three-dimensional cellular automaton. J Theor Biol (2000) 1.94
DSM-IV field trial: obsessive-compulsive disorder. Am J Psychiatry (1995) 1.93
The Massachusetts General Hospital (MGH) Hairpulling Scale: 1. development and factor analyses. Psychother Psychosom (1995) 1.92
Self-injurious skin picking: clinical characteristics and comorbidity. J Clin Psychiatry (1999) 1.87
Pattern of self-organization in tumour systems: complex growth dynamics in a novel brain tumour spheroid model. Cell Prolif (2001) 1.86
Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch Gen Psychiatry (1996) 1.77
Pilot studies of telemedicine for patients with obsessive-compulsive disorder. Am J Psychiatry (1995) 1.66
Isolation and characterization of cDNA clones to mouse macrophage and human endothelial cell tissue transglutaminases. J Biol Chem (1991) 1.60
Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapies. J Natl Cancer Inst (1998) 1.60
Genome-wide association study of obsessive-compulsive disorder. Mol Psychiatry (2012) 1.57
Complement depletion facilitates the infection of multiple brain tumors by an intravascular, replication-conditional herpes simplex virus mutant. J Virol (2000) 1.54
Magnetic resonance image-guided stereotactic cingulotomy for intractable psychiatric disease. Neurosurgery (1996) 1.53
The functional neuroanatomy of anxiety: a study of three disorders using positron emission tomography and symptom provocation. Biol Psychiatry (1997) 1.52
An infectious transfer and expression system for genomic DNA loci in human and mouse cells. Nat Biotechnol (2001) 1.46
Improvement in severe self-mutilation following limbic leucotomy: a series of 5 consecutive cases. J Clin Psychiatry (2001) 1.45
Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome. Mol Ther (2001) 1.45
Single-step conversion of cells to retrovirus vector producers with herpes simplex virus-Epstein-Barr virus hybrid amplicons. J Virol (1999) 1.43
Stereotaxic anterior cingulotomy for neuropsychiatric illness and intractable pain. J Neurosurg (1967) 1.43
Normal and disordered compulsivity: evidence against a continuum. J Clin Psychiatry (1989) 1.39
Relations between physicians and pharmaceutical companies: where to draw the line. N Engl J Med (1990) 1.39
Repetitive skin-picking in a student population and comparison with a sample of self-injurious skin-pickers. Psychosomatics (2000) 1.32
Treatment of psychiatric illness by stereotactic cingulotomy. Biol Psychiatry (1987) 1.31
Effects of innate immunity on herpes simplex virus and its ability to kill tumor cells. Gene Ther (2003) 1.31
Measuring transferrin receptor gene expression by NMR imaging. Biochim Biophys Acta (1998) 1.31
Characteristics of memory dysfunction in body dysmorphic disorder. J Int Neuropsychol Soc (2000) 1.30
Development of a rapid method to generate multiple oncolytic HSV vectors and their in vivo evaluation using syngeneic mouse tumor models. Gene Ther (2006) 1.29
MicroRNAs and glioblastoma; the stem cell connection. Cell Death Differ (2009) 1.27
Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy. Hum Gene Ther (1997) 1.26
The relationship between semantic organization and memory in obsessive-compulsive disorder. Psychother Psychosom (2000) 1.23
Sensory phenomena in obsessive-compulsive disorder and Tourette's disorder. J Clin Psychiatry (2000) 1.22
Organizational strategies mediate nonverbal memory impairment in obsessive-compulsive disorder. Biol Psychiatry (1999) 1.22
Obsessive-compulsive and related disorders: a hidden epidemic. N Engl J Med (1989) 1.21
A positron emission tomographic study of simple phobic symptom provocation. Arch Gen Psychiatry (1995) 1.20
B-myb promoter retargeting of herpes simplex virus gamma34.5 gene-mediated virulence toward tumor and cycling cells. J Virol (1999) 1.18
The Massachusetts General Hospital (MGH) Hairpulling Scale: 2. reliability and validity. Psychother Psychosom (1995) 1.16
Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene. Cancer Res (1994) 1.15
Stereotactic anterior cingulate lesions for persistent pain: a report on 68 cases. Clin Neurosurg (1974) 1.15
Severe hair loss associated with fluoxetine use. Am J Psychiatry (1991) 1.14
An oncolytic viral mutant that delivers the CYP2B1 transgene and augments cyclophosphamide chemotherapy. Nat Biotechnol (1998) 1.14
Probing striatal function in obsessive-compulsive disorder: a PET study of implicit sequence learning. J Neuropsychiatry Clin Neurosci (1997) 1.12
STUDIES ON VASOMOTOR TONE. I. THE EFFECT OF THE TETRA-ETHYLAMMONIUM ION ON THE PERIPHERAL BLOOD FLOW OF NORMAL SUBJECTS. J Clin Invest (1949) 1.12
Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo. Cancer Res (2001) 1.12
A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder. Arch Gen Psychiatry (1994) 1.12
Cellular automaton of idealized brain tumor growth dynamics. Biosystems (2000) 1.10
Reduced basal ganglia volumes in trichotillomania measured via morphometric magnetic resonance imaging. Biol Psychiatry (1997) 1.09
Clinical comparison of Tourette's disorder and obsessive-compulsive disorder. Am J Psychiatry (1987) 1.09
Oncolytic herpes virus with defective ICP6 specifically replicates in quiescent cells with homozygous genetic mutations in p16. Oncogene (2008) 1.06
Thymidine kinase activation of ganciclovir in recurrent malignant gliomas: a gene-marking and neuropathological study. J Neurosurg (2000) 1.06
Emergence of a subpopulation in a computational model of tumor growth. J Theor Biol (2000) 1.06
Directing systemic oncolytic viral delivery to tumors via carrier cells. Cytokine Growth Factor Rev (2010) 1.06
An oncolytic herpes simplex virus type 1 selectively destroys diffuse liver metastases from colon carcinoma. FASEB J (2000) 1.06
Strategic processing and episodic memory impairment in obsessive compulsive disorder. Neuropsychology (2000) 1.04
Pre-existing herpes simplex virus 1 (HSV-1) immunity decreases, but does not abolish, gene transfer to experimental brain tumors by a HSV-1 vector. Gene Ther (1998) 1.04
Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectors. Hum Gene Ther (1994) 1.03
The Skin Picking Scale: scale construction and psychometric analyses. J Psychosom Res (2001) 1.03
Phenomenological differences appearing with repetitive behaviours in obsessive-compulsive disorder and Gilles de la Tourette's syndrome. Br J Psychiatry (1997) 1.03
Comparison of intracerebral inoculation and osmotic blood-brain barrier disruption for delivery of adenovirus, herpesvirus, and iron oxide particles to normal rat brain. Am J Pathol (1995) 1.03
Phenomenology of intentional repetitive behaviors in obsessive-compulsive disorder and Tourette's disorder. J Clin Psychiatry (1995) 1.02
Enhancement of gene therapy specificity for diffuse colon carcinoma liver metastases with recombinant herpes simplex virus. Ann Surg (1996) 1.02
Antitumor activity and reporter gene transfer into rat brain neoplasms inoculated with herpes simplex virus vectors defective in thymidine kinase or ribonucleotide reductase. Gene Ther (1994) 1.02
Herpes vector-mediated delivery of marker genes to disseminated central nervous system tumors. Hum Gene Ther (1996) 1.02
Transgene inheritance and retroviral infection contribute to the efficiency of gene expression in solid tumors inoculated with retroviral vector producer cells. Gene Ther (1995) 1.01
Primary lymphoma of peripheral nerve: report of four cases. Am J Surg Pathol (2000) 1.00
Gene therapy for brain tumors. Brain Pathol (1995) 1.00
Progress and prospects: gene therapy clinical trials (part 2). Gene Ther (2007) 1.00
Multimodal cancer treatment mediated by a replicating oncolytic virus that delivers the oxazaphosphorine/rat cytochrome P450 2B1 and ganciclovir/herpes simplex virus thymidine kinase gene therapies. Cancer Res (1999) 1.00
Management of brain abscesses in children and adolescents. Am J Dis Child (1967) 0.99
Inhibition of NF2-negative and NF2-positive primary human meningioma cell proliferation by overexpression of merlin due to vector-mediated gene transfer. J Neurosurg (1999) 0.99
Experimental tumor therapy in mice using the cyclophosphamide-activating cytochrome P450 2B1 gene. Hum Gene Ther (1994) 0.98
New prodrug activation gene therapy for cancer using cytochrome P450 4B1 and 2-aminoanthracene/4-ipomeanol. Hum Gene Ther (1998) 0.97
Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for obsessive compulsive disorder. Biol Psychiatry (2001) 0.97
Tourette's disorder with and without obsessive-compulsive disorder in adults: are they different? J Nerv Ment Dis (1998) 0.97
Comparative analyses of transgene delivery and expression in tumors inoculated with a replication-conditional or -defective viral vector. Cancer Res (2001) 0.95
Infectious delivery of the 132 kb CDKN2A/CDKN2B genomic DNA region results in correctly spliced gene expression and growth suppression in glioma cells. Gene Ther (2004) 0.95
Cancer gene therapy using a replication-competent herpes simplex virus type 1 vector. Ann Surg (1998) 0.95
Longitudinal follow-up of naturalistic treatment outcome in patients with trichotillomania. J Clin Psychiatry (2001) 0.94
The subtemporal-transpetrous approach for excision of petroclival tumors. Am J Otol (1996) 0.94
Meta-analysis of association between obsessive-compulsive disorder and the 3' region of neuronal glutamate transporter gene SLC1A1. Am J Med Genet B Neuropsychiatr Genet (2013) 0.93
Spontaneous thrombosis in a giant middle cerebral artery aneurysm. Case report. J Neurosurg (1972) 0.92
Trichotillomania and carpal tunnel syndrome. J Clin Psychiatry (1996) 0.92
Genetic strategies for brain tumor therapy. Cancer Gene Ther (2006) 0.92
Solitary sciatic nerve lymphoma as an initial manifestation of diffuse neurolymphomatosis. Case report and review of the literature. J Neurosurg (2000) 0.92
Oncolysis of diffuse hepatocellular carcinoma by intravascular administration of a replication-competent, genetically engineered herpesvirus. Cancer Res (2000) 0.92
Diffusible cytotoxic metabolites contribute to the in vitro bystander effect associated with the cyclophosphamide/cytochrome P450 2B1 cancer gene therapy paradigm. Clin Cancer Res (1995) 0.91
Cerebrovascular Biology and the various neural barriers: challenges and future directions. Neurosurgery (1999) 0.91
Alprazolam as treatment for a case of obsessive-compulsive disorder. Am J Psychiatry (1984) 0.91
Use of a portable computer program to assist behavioral treatment in a case of obsessive compulsive disorder. J Behav Ther Exp Psychiatry (1988) 0.91